Franseen Needles May Be Promising for Improving the Sampling Adequacy of EUS-FNA for Subepithelial Lesions.
SEL
endoscopic ultrasound-guided fine needle aspiration
multivariate analysis
sampling adequacy rate
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
09 Jul 2022
09 Jul 2022
Historique:
received:
13
06
2022
revised:
06
07
2022
accepted:
06
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is useful in diagnosing subepithelial lesions (SELs), and adequate tissue sampling is necessary to differentiate between benign and malignant diseases to determine therapeutic strategies. This study aimed to evaluate sampling adequacy and diagnostic performance of EUS-FNA for SELs with Franseen needles. This retrospective study enrolled 130 patients who underwent EUS-FNA with a 22-gauge needle for SELs from January 2010 to March 2021. We compared sampling adequacy and predictive factors influencing the sampling adequacy of EUS-FNA for SELs between Franseen and conventional needles. The sampling adequacy rates were 95.0% (38/40) with Franseen needles and 76.7% (69/90) with conventional needles (p = 0.011). The mean number of punctures with Franseen needles (2.80) was significantly less than that with conventional needles (3.42) (p < 0.001). In the multivariate analysis, the use of Franseen needles (p = 0.029; odds ratio [OR], 5.37; 95% confidence interval [CI], 1.18−23.36) was an independent factor influencing the sampling adequacy. Compared to conventional needles, the Franseen needle could play a vital role in accurately diagnosing SELs by yielding better sampling adequacy and reducing the number of passes.
Identifiants
pubmed: 35885571
pii: diagnostics12071667
doi: 10.3390/diagnostics12071667
pmc: PMC9322475
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Endosc Int Open. 2019 Oct;7(10):E1221-E1230
pubmed: 31579703
Gastrointest Endosc. 2011 Sep;74(3):504-10
pubmed: 21872709
Gastrointest Endosc. 2010 Mar;71(3):446-54
pubmed: 20189503
Endoscopy. 2011 Aug;43(8):709-15
pubmed: 21611946
Dig Endosc. 2017 May;29(3):338-346
pubmed: 27878861
Endosc Ultrasound. 2016 May-Jun;5(3):157-64
pubmed: 27386472
Virchows Arch. 2001 Jan;438(1):1-12
pubmed: 11213830
World J Gastroenterol. 2007 Apr 14;13(14):2077-82
pubmed: 17465451
Am J Gastroenterol. 2015 Oct;110(10):1429-39
pubmed: 26346868
Endosc Ultrasound. 2020 May-Jun;9(3):167-174
pubmed: 31031330
Arq Bras Cir Dig. 2018 Jun 21;31(1):e1350
pubmed: 29947684
Am J Gastroenterol. 2012 Mar;107(3):397-404
pubmed: 21989147
Surg Endosc. 1991;5(1):20-3
pubmed: 1871670
J Ultrasound. 2022 Mar;25(1):35-40
pubmed: 33511507
Gastrointest Endosc. 2020 Jul;92(1):108-119.e3
pubmed: 32105712
Gastrointest Endosc. 2010 May;71(6):913-9
pubmed: 20226456
Gastrointest Endosc. 2015 Sep;82(3):550-6.e1
pubmed: 25887718
Gastric Cancer. 2016 Jan;19(1):3-14
pubmed: 26276366
Endosc Ultrasound. 2019 Jan-Feb;8(1):50-57
pubmed: 29786033
Endosc Ultrasound. 2017 May-Jun;6(3):156-161
pubmed: 28621291
Endosc Int Open. 2017 May;5(5):E363-E375
pubmed: 28497108
Gastrointest Endosc. 2009 Mar;69(3 Pt 1):509-16
pubmed: 19231491
Gastrointest Endosc. 2017 Sep;86(3):510-515
pubmed: 28131864
Mol Clin Oncol. 2018 Nov;9(5):527-531
pubmed: 30345047
J Gastric Cancer. 2020 Mar;20(1):29-40
pubmed: 32269842
Cancers (Basel). 2021 Jun 24;13(13):
pubmed: 34202544
Gastrointest Endosc. 2018 Jun;87(6):1432-1438
pubmed: 29305893
Gastrointest Endosc. 2002 Jan;55(1):37-43
pubmed: 11756912
Gut Liver. 2016 Jan;10(1):51-7
pubmed: 25963081
World J Gastroenterol. 2014 Jul 28;20(28):9451-7
pubmed: 25071339